#BEGIN_DRUGCARD DB04350

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
289665-92-5

# ChEBI_ID:
Not Available

# Chemical_Formula:
C29H42N10O9

# Chemical_IUPAC_Name:
4-[(1S,4R,10S,13S,16S,18R)-10-{3-[(E)-[amino(acetamido)methylidene]amino]propyl}-18-hydroxy-16-(1H-imidazol-5-ylmethyl)-3,9,12,15,20-pentaoxo-2,8,11,14,17-pentaazatricyclo[15.2.1.0^{4,8}]icosan-13-yl]butanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Argadin

# HET_ID:
RIG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C29H42N10O9/c1-15(40)34-29(30)32-9-3-6-18-27(47)38-10-4-7-20(38)25(45)37-19-12-22(41)39(28(19)48)21(11-16-13-31-14-33-16)26(46)35-17(24(44)36-18)5-2-8-23(42)43/h13-14,17-22,41H,2-12H2,1H3,(H,31,33)(H,35,46)(H,36,44)(H,37,45)(H,42,43)(H3,30,32,34,40)/t17-,18-,19-,20+,21-,22+/m0/s1

# InChI_Key:
InChIKey=FOZYKTUSOWWQGR-KNPYFFGGSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4350

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
674.7054

# Molecular_Weight_Mono:
674.313622992

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1W9U

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.8

# Predicted_LogS:
-2.8

# Predicted_Water_Solubility:
1.14e+00 g/l

# Primary_Accession_No:
DB04350

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
449123

# PubChem_Substance_ID:
46508598

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02785

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(=O)N\C(N)=N\CCC[C@@H]1NC(=O)[C@H](CCCC(O)=O)NC(=O)[C@H](CC2=CN=CN2)N2[C@H](O)C[C@H](NC(=O)[C@H]3CCCN3C1=O)C2=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
FO 7314

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:14 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AY217660

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
chiB1

# Drug_Target_1_Gene_Sequence:
>1302 bp
ATGCGCTTTGCAACTTCCACCATCGTCAAGGTCGCCCTTCTGCTTAGCAGTCTTTGTGTC
GACGCCGCAGTGATGTGGAATCGTGATACCAGTAGTACTGATCTGGAGGCGCGCGCTAGC
TCCGGTTATCGCTCGGTCGTCTACTTTGTCAACTGGGCAATTTACGGGCGCAACCATAAT
CCCCAGGATCTTCCTGTCGAGAGGCTCACGCACGTGCTCTACGCCTTTGCAAATGTGCGC
CCTGAAACGGGGGAAGTCTATATGACAGACTCTTGGGCTGATATTGAGAAACATTACCCC
GGTGACTCCTGGTCTGATACTGGCAACAATGTCTATGGCTGTATCAAACAGTTGTATCTC
TTGAAGAAGCAGAACCGTAACCTCAAGGTTCTCTTGTCCATTGGCGGGTGGACCTACTCT
CCCAACTTTGCTCCGGCGGCTAGTACCGACGCTGGACGGAAGAACTTTGCGAAGACTGCG
GTGAAGCTGCTGCAGGACCTGGGATTTGATGGACTGGATATTGATTGGGAGTACCCTGAA
AACGACCAGCAAGCGAACGACTTTGTTCTGTTGCTGAAGGAAGTGAGAACTGCCCTCGAC
AGTTACAGTGCTGCAAATGCGGGCGGCCAGCACTTCCTTCTGACGGTGGCTTCTCCAGCT
GGTCCCGATAAGATCAAGGTCCTTCACCTCAAGGACATGGATCAGCAATTGGACTTCTGG
AATCTCATGGCCTACGATTATGCTGGCAGTTTCTCCTCCCTCAGCGGCCATCAAGCGAAC
GTCTACAACGACACCTCCAACCCGCTCTCCACACCATTCAACACCCAGACGGCACTCGAT
CTGTATCGCGCCGGCGGAGTCCCCGCCAACAAAATCGTTCTAGGCATGCCTCTCTACGGC
CGCTCATTCGCCAACACCGACGGACCTGGTAAGCCTTATAACGGCGTTGGCCAGGGTAGC
TGGGAGAATGGAGTGTGGGACTACAAGGCGCTCCCTCAAGCTGGCGCCACGGAGCATGTC
CTTCCCGACATCATGGCGAGCTACAGCTACGACGCGACAAACAAGTTCTTGATCAGCTAT
GACAACCCTCAAGTGGCGAATCTGAAGTCTGGCTATATCAAGTCCTTGGGATTGGGAGGC
GCCATGTGGTGGGACAGCAGCAGCGACAAGACCGGAAGTGATAGTCTGATTACCACGGTA
GTAAATGCACTCGGAGGCACGGGAGTCTTCGAACAGAGTCAGAATGAATTGGACTATCCG
GTGTCGCAGTATGATAACCTGCGCAATGGCATGCAAACCTGA

# Drug_Target_1_General_Function:
Involved in chitinase activity

# Drug_Target_1_General_References:
14523125	Jaques AK, Fukamizo T, Hall D, Barton RC, Escott GM, Parkinson T, Hitchcock CA, Adams DJ: Disruption of the gene encoding the ChiB1 chitinase of Aspergillus fumigatus and characterization of a recombinant gene product. Microbiology. 2003 Oct;149(Pt 10):2931-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5362

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
47622

# Drug_Target_1_Name:
Chitinase

# Drug_Target_1_Number_of_Residues:
433

# Drug_Target_1_PDB_ID:
1W9V

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00704	Glyco_hydro_18

# Drug_Target_1_Protein_Sequence:
>Chitinase
MRFATSTIVKVALLLSSLCVDAAVMWNRDTSSTDLEARASSGYRSVVYFVNWAIYGRNHN
PQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCIKQLYL
LKKQNRNLKVLLSIGGWTYSPNFAPAASTDAGRKNFAKTAVKLLQDLGFDGLDIDWEYPE
NDQQANDFVLLLKEVRTALDSYSAANAGGQHFLLTVASPAGPDKIKVLHLKDMDQQLDFW
NLMAYDYAGSFSSLSGHQANVYNDTSNPLSTPFNTQTALDLYRAGGVPANKIVLGMPLYG
RSFANTDGPGKPYNGVGQGSWENGVWDYKALPQAGATEHVLPDIMASYSYDATNKFLISY
DNPQVANLKSGYIKSLGLGGAMWWDSSSDKTGSDSLITTVVNALGGTGVFEQSQNELDYP
VSQYDNLRNGMQT

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q873X9

# Drug_Target_1_SwissProt_Name:
Q873X9_ASPFM

# Drug_Target_1_Synonyms:
Class V chitinase ChiB1

# Drug_Target_1_Theoretical_pI:
4.85

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Secreted protein. Lysosome. Note=A small proportion is lysosomal

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
CHIT1

# Drug_Target_2_GenBank_ID_Gene:
U29615

# Drug_Target_2_GenBank_ID_Protein:
1050958

# Drug_Target_2_GeneCard_ID:
CHIT1

# Drug_Target_2_Gene_Name:
CHIT1

# Drug_Target_2_Gene_Sequence:
>1401 bp
ATGGTGCGGTCTGTGGCCTGGGCAGGTTTCATGGTCCTGCTGATGATCCCATGGGGCTCT
GCTGCAAAACTGGTCTGCTACTTCACCAACTGGGCCCAGTACAGACAGGGGGAGGCTCGC
TTCCTGCCCAAGGACTTGGACCCCAGCCTTTGCACCCACCTCATCTACGCCTTCGCTGGC
ATGACCAACCACCAGCTGAGCACCACTGAGTGGAATGACGAGACTCTCTACCAGGAGTTC
AATGGCCTGAAGAAGATGAATCCCAAGCTGAAGACCCTGTTAGCCATCGGAGGCTGGAAT
TTCGGCACTCAGAAGTTCACAGATATGGTAGCCACGGCCAACAACCGTCAGACCTTTGTC
AACTCGGCCATCAGGTTTCTGCGCAAATACAGCTTTGACGGCCTTGACCTTGACTGGGAG
TACCCAGGAAGCCAGGGGAGCCCTGCCGTAGACAAGGAGCGCTTCACAACCCTGGTACAG
GACTTGGCCAATGCCTTCCAGCAGGAAGCCCAGACCTCAGGGAAGGAACGCCTTCTTCTG
AGTGCAGCGGTTCCAGCTGGGCAGACCTATGTGGATGCTGGATACGAGGTGGACAAAATC
GCCCAGAACCTGGATTTTGTCAACCTTATGGCCTACGACTTCCATGGCTCTTGGGAGAAG
GTCACGGGACATAACAGCCCCCTCTACAAGAGGCAAGAAGAGAGTGGTGCAGCAGCCAGC
CTCAACGTGGATGCTGCTGTGCAACAGTGGCTGCAGAAGGGGACCCCTGCCAGCAAGCTG
ATCCTTGGCATGCCTACCTACGGACGCTCCTTCACACTGGCCTCCTCATCAGACACCAGA
GTGGGGGCCCCAGCCACAGGGTCTGGCACTCCAGGCCCCTTCACCAAGGAAGGAGGGATG
CTGGCCTACTATGAAGTCTGCTCCTGGAAGGGGGCCACCAAACAGAGAATCCAGGATCAG
AAGGTGCCCTACATCTTCCGGGACAACCAGTGGGTGGGCTTTGATGATGTGGAGAGCTTC
AAAACCAAGGTCAGCTATCTGAAGCAGAAGGGACTGGGCGGGGCCATGGTCTGGGCACTG
GACTTAGATGACTTTGCCGGCTTCTCCTGCAACCAGGGCCGATACCCCCTCATCCAGACG
CTACGGCAGGAACTGAGTCTTCCATACTTGCCTTCAGGCACCCCAGAGCTTGAAGTTCCA
AAACCAGGTCAGCCCTCTGAACCTGAGCATGGCCCCAGCCCTGGACAAGACACGTTCTGC
CAGGGCAAAGCTGATGGGCTCTATCCCAATCCTCGGGAACGGTCCAGCTTCTACAGCTGT
GCAGCGGGGCGGCTGTTCCAGCAAAGCTGCCCGACAGGCCTGGTGTTCAGCAACTCCTGC
AAATGCTGCACCTGGAATTGA

# Drug_Target_2_General_Function:
Involved in chitinase activity

# Drug_Target_2_General_References:
11960986	Fusetti F, von Moeller H, Houston D, Rozeboom HJ, Dijkstra BW, Boot RG, Aerts JM, van Aalten DM: Structure of human chitotriosidase. Implications for specific inhibitor design and function of mammalian chitinase-like lectins. J Biol Chem. 2002 Jul 12;277(28):25537-44. Epub 2002 Apr 17.
7592832	Boot RG, Renkema GH, Strijland A, van Zonneveld AJ, Aerts JM: Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem. 1995 Nov 3;270(44):26252-6.
7836450	Renkema GH, Boot RG, Muijsers AO, Donker-Koopman WE, Aerts JM: Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J Biol Chem. 1995 Feb 3;270(5):2198-202.
9748235	Boot RG, Renkema GH, Verhoek M, Strijland A, Bliek J, de Meulemeester TM, Mannens MM, Aerts JM: The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem. 1998 Oct 2;273(40):25680-5.

# Drug_Target_2_HGNC_ID:
HGNC:1936

# Drug_Target_2_HPRD_ID:
02494

# Drug_Target_2_ID:
1682

# Drug_Target_2_Locus:
1q31-q32

# Drug_Target_2_Molecular_Weight:
51682

# Drug_Target_2_Name:
Chitotriosidase-1

# Drug_Target_2_Number_of_Residues:
466

# Drug_Target_2_PDB_ID:
1WB0

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00704	Glyco_hydro_18
PF01607	CBM_14

# Drug_Target_2_Protein_Sequence:
>Chitotriosidase-1 precursor
MVRSVAWAGFMVLLMIPWGSAAKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAG
MTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFV
NSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLL
SAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAAS
LNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGM
LAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWAL
DLDDFAGFSCNQGRYPLIQTLRQELSLPYLPSGTPELEVPKPGQPSEPEHGPSPGQDTFC
QGKADGLYPNPRERSSFYSCAAGRLFQQSCPTGLVFSNSCKCCTWN

# Drug_Target_2_Reaction:
Random hydrolysis of N-acetyl-beta-D-glucosaminide 1,4-beta-linkages in chitin and chitodextrins ALL_REAC (other) R01206 R02334 R06081(G) R06082(G) INHIBITOR Allosamidine

# Drug_Target_2_Signals:
1-21

# Drug_Target_2_Specific_Function:
Degrades chitin and chitotriose. May participate in the defense against nematodes and other pathogens. Isoform 3 has no enzymatic activity

# Drug_Target_2_SwissProt_ID:
Q13231

# Drug_Target_2_SwissProt_Name:
CHIT1_HUMAN

# Drug_Target_2_Synonyms:
Chitinase-1
Chitotriosidase-1 precursor
EC 3.2.1.14

# Drug_Target_2_Theoretical_pI:
6.96

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04350
